Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis

Stephanie D. Boomkamp, Hoe-Sup Byun, Satvir Ubhi, Hui-Rong Jiang, Susan Pyne, Robert Bittman, Nigel J. Pyne

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We have assessed the effect of two ether glycerol lipids, 77-6 ((2S, 3R)-4-(Tetradecyloxy)-2-amino-1,3-butanediol) and 56-5 ((S)-2-Amino-3-O-hexadecyl-1-propanol), which are substrates for sphingosine kinases, on inflammatory responses. Treatment of differentiated U937 macrophage-like cells with 77-6 but not 56-5 enhanced IL-1β release; either alone or in the presence of LPS. The stimulatory effect of sphingosine or 77-6 on LPS-stimulated IL-1β release was reduced by pretreatment of cells with the caspase-1 inhibitor, Ac-YVAD-CHO, thereby indicating a role for the inflammasome. The enhancement of LPS-stimulated IL-1β release in response to sphingosine, but not 77-6, was reduced by pretreatment of cells with the cathepsin B inhibitor, CA074Me, indicating a role for lysosomal destabilization in the effect of sphingosine. Administration of 56-5 to mice increased disease progression in an experimental autoimmune encephalomyelitis model and this was associated with a considerable increase in the infiltration of CD4+ T-cells, CD11b+ monocytes and F4/80+ macrophages in the spinal cord. 56-5 and 77-6 were without effect on the degradation of myc-tagged sphingosine 1-phosphate 1 receptor in CCL39 cells. Therefore, the effect of 56-5 on EAE disease progression is likely to be independent of the inflammasome or the sphingosine 1-phosphate 1 receptor. However, 56-5 is chemically similar to platelet activating factor and the exacerbation of EAE disease progression might be linked to platelet activating factor receptor signaling.
LanguageEnglish
Pages2-11
Number of pages10
JournalChemistry and Physics of Lipids
Volume194
Early online date14 Jul 2015
DOIs
Publication statusPublished - 1 Jan 2016

Fingerprint

Glyceryl Ethers
Sphingosine
Autoimmune Experimental Encephalomyelitis
Interleukin-1beta
Inflammasomes
Macrophages
Lysosphingolipid Receptors
Lipids
Disease Progression
Cells
1-Propanol
Cathepsin B
T-cells
Platelet Activating Factor
Infiltration
Interleukin-5
Monocytes
Degradation
Spinal Cord
Substrates

Keywords

  • Caspase-1
  • sphingosine
  • multiple sclerosis
  • interleukin-1
  • inflammasome
  • ether glycerol lipids

Cite this

@article{1e3e54c231474a8fa0f7a0a9cb46eaff,
title = "Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis",
abstract = "We have assessed the effect of two ether glycerol lipids, 77-6 ((2S, 3R)-4-(Tetradecyloxy)-2-amino-1,3-butanediol) and 56-5 ((S)-2-Amino-3-O-hexadecyl-1-propanol), which are substrates for sphingosine kinases, on inflammatory responses. Treatment of differentiated U937 macrophage-like cells with 77-6 but not 56-5 enhanced IL-1β release; either alone or in the presence of LPS. The stimulatory effect of sphingosine or 77-6 on LPS-stimulated IL-1β release was reduced by pretreatment of cells with the caspase-1 inhibitor, Ac-YVAD-CHO, thereby indicating a role for the inflammasome. The enhancement of LPS-stimulated IL-1β release in response to sphingosine, but not 77-6, was reduced by pretreatment of cells with the cathepsin B inhibitor, CA074Me, indicating a role for lysosomal destabilization in the effect of sphingosine. Administration of 56-5 to mice increased disease progression in an experimental autoimmune encephalomyelitis model and this was associated with a considerable increase in the infiltration of CD4+ T-cells, CD11b+ monocytes and F4/80+ macrophages in the spinal cord. 56-5 and 77-6 were without effect on the degradation of myc-tagged sphingosine 1-phosphate 1 receptor in CCL39 cells. Therefore, the effect of 56-5 on EAE disease progression is likely to be independent of the inflammasome or the sphingosine 1-phosphate 1 receptor. However, 56-5 is chemically similar to platelet activating factor and the exacerbation of EAE disease progression might be linked to platelet activating factor receptor signaling.",
keywords = "Caspase-1, sphingosine, multiple sclerosis, interleukin-1, inflammasome, ether glycerol lipids",
author = "Boomkamp, {Stephanie D.} and Hoe-Sup Byun and Satvir Ubhi and Hui-Rong Jiang and Susan Pyne and Robert Bittman and Pyne, {Nigel J.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.chemphyslip.2015.07.001",
language = "English",
volume = "194",
pages = "2--11",
journal = "Chemistry and Physics of Lipids",
issn = "0009-3084",

}

Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis. / Boomkamp, Stephanie D.; Byun, Hoe-Sup; Ubhi, Satvir; Jiang, Hui-Rong; Pyne, Susan; Bittman, Robert; Pyne, Nigel J.

In: Chemistry and Physics of Lipids, Vol. 194, 01.01.2016, p. 2-11.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis

AU - Boomkamp, Stephanie D.

AU - Byun, Hoe-Sup

AU - Ubhi, Satvir

AU - Jiang, Hui-Rong

AU - Pyne, Susan

AU - Bittman, Robert

AU - Pyne, Nigel J.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - We have assessed the effect of two ether glycerol lipids, 77-6 ((2S, 3R)-4-(Tetradecyloxy)-2-amino-1,3-butanediol) and 56-5 ((S)-2-Amino-3-O-hexadecyl-1-propanol), which are substrates for sphingosine kinases, on inflammatory responses. Treatment of differentiated U937 macrophage-like cells with 77-6 but not 56-5 enhanced IL-1β release; either alone or in the presence of LPS. The stimulatory effect of sphingosine or 77-6 on LPS-stimulated IL-1β release was reduced by pretreatment of cells with the caspase-1 inhibitor, Ac-YVAD-CHO, thereby indicating a role for the inflammasome. The enhancement of LPS-stimulated IL-1β release in response to sphingosine, but not 77-6, was reduced by pretreatment of cells with the cathepsin B inhibitor, CA074Me, indicating a role for lysosomal destabilization in the effect of sphingosine. Administration of 56-5 to mice increased disease progression in an experimental autoimmune encephalomyelitis model and this was associated with a considerable increase in the infiltration of CD4+ T-cells, CD11b+ monocytes and F4/80+ macrophages in the spinal cord. 56-5 and 77-6 were without effect on the degradation of myc-tagged sphingosine 1-phosphate 1 receptor in CCL39 cells. Therefore, the effect of 56-5 on EAE disease progression is likely to be independent of the inflammasome or the sphingosine 1-phosphate 1 receptor. However, 56-5 is chemically similar to platelet activating factor and the exacerbation of EAE disease progression might be linked to platelet activating factor receptor signaling.

AB - We have assessed the effect of two ether glycerol lipids, 77-6 ((2S, 3R)-4-(Tetradecyloxy)-2-amino-1,3-butanediol) and 56-5 ((S)-2-Amino-3-O-hexadecyl-1-propanol), which are substrates for sphingosine kinases, on inflammatory responses. Treatment of differentiated U937 macrophage-like cells with 77-6 but not 56-5 enhanced IL-1β release; either alone or in the presence of LPS. The stimulatory effect of sphingosine or 77-6 on LPS-stimulated IL-1β release was reduced by pretreatment of cells with the caspase-1 inhibitor, Ac-YVAD-CHO, thereby indicating a role for the inflammasome. The enhancement of LPS-stimulated IL-1β release in response to sphingosine, but not 77-6, was reduced by pretreatment of cells with the cathepsin B inhibitor, CA074Me, indicating a role for lysosomal destabilization in the effect of sphingosine. Administration of 56-5 to mice increased disease progression in an experimental autoimmune encephalomyelitis model and this was associated with a considerable increase in the infiltration of CD4+ T-cells, CD11b+ monocytes and F4/80+ macrophages in the spinal cord. 56-5 and 77-6 were without effect on the degradation of myc-tagged sphingosine 1-phosphate 1 receptor in CCL39 cells. Therefore, the effect of 56-5 on EAE disease progression is likely to be independent of the inflammasome or the sphingosine 1-phosphate 1 receptor. However, 56-5 is chemically similar to platelet activating factor and the exacerbation of EAE disease progression might be linked to platelet activating factor receptor signaling.

KW - Caspase-1

KW - sphingosine

KW - multiple sclerosis

KW - interleukin-1

KW - inflammasome

KW - ether glycerol lipids

UR - http://www.sciencedirect.com/science/article/pii/S0009308415300062

U2 - 10.1016/j.chemphyslip.2015.07.001

DO - 10.1016/j.chemphyslip.2015.07.001

M3 - Article

VL - 194

SP - 2

EP - 11

JO - Chemistry and Physics of Lipids

T2 - Chemistry and Physics of Lipids

JF - Chemistry and Physics of Lipids

SN - 0009-3084

ER -